Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
KYLYS logo — BIOMOLECULES NOW, FOR YOUR FUTURE

KYLYS

BIOMOLECULES NOW, FOR YOUR FUTURE

Founded 2017 Switzerland Plan-les-ouates, Switzerland 3 employees Debt Financing Total: $100.00K Biotechnology, Life Sciences +1

General Information

Company Name KYLYS
Founded Year 2017
Location Switzerland Plan-les-ouates, Switzerland
Employees 3
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with KYLYS. To contact KYLYS, visit kylys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KYLYS compare?

A PDF of KYLYS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KYLYS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KYLYS

KYLYS is a Life Science Spin-off from the University of Geneva, dedicated to advancing into clinical development. Their focus on science and biotechnology drives their ambition to pioneer a unique technology for highly effective and safe products utilizing the next generation of hyaluronic acid (HA). The company's offerings span across aesthetic and medical realms, under KYLYS Aesthetics and KYLYS respectively. KYLYS is positioned to disrupt the HA delivery landscape within various fields including aesthetic, rheumatology, reconstructive surgery, drug delivery system, and even veterinary applications. Founded in 2017 and headquartered in Switzerland, the latest injection of funds amounting to Fr.100.00K came in the form of Debt Financing from FONGIT on 16 May 2023. This recent investment signals confidence from a notable investor, accelerating KYLYS's trajectory towards groundbreaking advancements in biotechnology and the pharmaceutical industry.

Business keywords: Life Science, Clinical Development, Hyaluronic Acid, Aesthetic Products, Medical Products, Rheumatology, Reconstructive Surgery, Drug Delivery, Veterinary Medicine, University Spin-off

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Fr.100.00K 1
FONGIT
FONGIT
16 May 2023
Seed Round Undisclosed 1
Eclosion SA
Eclosion SA
01 Jan 2018

KYLYS Alternatives & Competitors

KYLYS vs
Bioxis Pharmaceuticals
Bioxis Pharmaceuticals France

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine

Venture round
28 employees
Biotechnology, Medical Devices
KYLYS vs
CEBIOTEX
CEBIOTEX Spain

Providing solutions for patients with cancer by helping surgeons in their oncological interventions.

Equity Crowdfunding
8 employees
Biotechnology, Health Care
KYLYS vs
Formac Pharmaceuticals
Formac Pharmaceuticals Belgium

World leader in the development of best in class new pharmaceutical products. FORMAC Applies its sil...

Grant
3 employees
Biotechnology, Health Care

FAQ About KYLYS

BIOMOLECULES NOW, FOR YOUR FUTURE
KYLYS was founded in 2017.
KYLYS is headquartered in Plan-les-ouates, Switzerland.
KYLYS operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Life Science, Clinical Development, Hyaluronic Acid and Aesthetic Products.
KYLYS has approximately 3 employees.
KYLYS has completed 2 funding rounds, raising a total of $100.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to KYLYS include Bioxis Pharmaceuticals, CEBIOTEX, Formac Pharmaceuticals, Cybrexa Therapeutics, BioAesthetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KYLYS and Bioxis Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KYLYS, https://bouncewatch.com/company/kylys, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes